Insider Trades at Bonterra Energy Signal Confidence Amid Strong Financial Performance
Bonterra Energy Corp. (BNE:CA) is a Canadian company engaged in conventional oil and gas activities, primarily operating in Alberta, Saskatchewan, and British Columbia. The company focuses on developing and producing oil and natural gas within the Western Canadian Sedimentary Basin. It is publicly traded on the Toronto Stock Exchange, with a market capitalization almost valued at CAD 234.7 million.
Insiders’ Confidence Move
During March, two insiders demonstrated confidence in the oil and gas company.
On March 12, Chairman of the Board Donald Michael Godfrey Stewart acquired 5,226 shares at CAD 5.89 per share, resulting in a total investment of CAD 30,776 ($22,809).
Additionally, between March 15 and March 26, President/CEO Patrick George Oliver purchased 20,000 shares at an average price of CAD 6.19 per share, accumulating an investment of around CAD 124,000.
Robust Financial Standing
In 2023, Bonterra Energy Corp. experienced significant growth, with average daily production reaching 14,204 BOE, a 6% increase from 2022. Funds flow for the year totaled $147.3 million, with Q4 2023 seeing $40.4 million. Net earnings demonstrated full-cycle profitability, totaling $44.9 million ($1.20 per diluted share) for the year and $15.0 million ($0.40 per diluted share) in Q4 2023.
Production costs declined, with Q4 2023 costs 17% lower than Q4 2022, averaging $13.37 per BOE. Annual average production costs decreased by 8% from 2022 to $16.02 per BOE. Additionally, net debt decreased by six percent to $140.4 million by year-end compared to 2022.
By the analysis of such strong results, it won’t be wrong to say that insider trades can be decrypted as potential indicators for the firm's bullish future.
Latest Stories
Understanding Stock Buybacks: How Companies Boost Shareholder Value
Insider Confidence Fuels Hyliion’s Green Energy Vision
Insider Selling at Sol Strategies: Executives Cash out After Price Surge
Carl Icahn’s Form 144 Filing Hints at $109.96M Southwest Gas Exit; The Start of Something Bigger?
Insider Confidence and Promising Growth at Celldex Therapeutics